================================================================================

                       SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549

                                   FORM 10-QSB

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (D) OF THE SECURITIES EXCHANGE
    ACT OF 1934

                FOR THE QUARTERLY PERIOD ENDED DECEMBER 31, 2006

                                       OR

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (D) OF THE SECURITIES
    EXCHANGE ACT OF 1934

     For the transition period from ________________ to ___________________

                        Commission file number: 000-50292

                                 MM2 GROUP, INC.
--------------------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)

         NEW JERSEY                                              20-255483
--------------------------------------------------------------------------------
(State or other jurisdiction of                               (I.R.S. Employer
 incorporation or organization)                             Identification No.)

5 REGENT STREET, SUITE 520
LIVINGSTON, NJ                                                     07039
--------------------------------------------------------------------------------
(Address of Principal Executive Offices)                         (Zip Code)

Registrant's Telephone Number, Including Area Code:  (732) 290-0019

The former name of the registrant was Wien Group, Inc. The former address of the
registrant was 525 Washington Blvd., Jersey City, New Jersey, 07310

Securities registered under Section 12(b) of the Exchange Act: NONE.

Securities registered under Section 12(g) of the Exchange Act: CLASS A COMMON,
NO PAR VALUE

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934
during the preceding 12 months (or for such shorter period that the registrant
was required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. YES [X] NO [ ]

Indicate by check mark whether the registrant is a shell company (as defined in
Rule 12b-2 of the Exchange Act).  YES [ ] NO [X]

Number of shares of Class A, common stock,
  No par value, outstanding as of February 19, 2007: 143,713,436

Transitional Small Business Disclosure Format (check one).  YES [ ] NO [X]
================================================================================
<PAGE>

            MM2 GROUP, INC (F/K/A/ WIEN GROUP, INC.) AND SUBSIDIARIES
                   CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                                DECEMBER 31, 2006


                                TABLE OF CONTENTS
                                -----------------


                                                                       Page No.
                                                                       --------

PART I.                      FINANCIAL INFORMATION


Item 1.  Condensed Consolidated Financial Statements (Unaudited)

         Balance Sheet - December 31, 2006                                2 - 3

         Statements of Operations - For the six months and three
                  months ended  December 31, 2006 and 2005                  4

         Statements of Cash Flows - For the six months ended
                 December 31, 2006 and 2005                               5 - 7

         Notes to Condensed Consolidated Financial Statements             8 - 22


Item 2.  Management's Discussion and Analysis or Plan of Operations      23 - 27


Item 3.  Controls and Procedures                                         28 - 29

PART II. OTHER INFORMATION

Item 6.  Exhibits                                                          30

                                        1
<PAGE>

            MM2 GROUP, INC (F/K/A/ WIEN GROUP, INC.) AND SUBSIDIARIES
                CONDENSED CONSOLIDATED BALANCE SHEET (UNAUDITED)
                                DECEMBER 31, 2006

                                     ASSETS
                                     ------


CURRENT ASSETS
Cash and cash equivalents                                            $  405,080
Accounts receivable, net of allowance for doubtful accounts of $0       228,357
Inventory                                                                29,982
Prepaid expenses                                                        139,548
                                                                     ----------
    Total current assets                                                802,967
                                                                     ----------

PROPERTY AND EQUIPMENT, net of accumulated depreciation of $1,459         4,119
                                                                     ----------

OTHER ASSETS
Goodwill                                                                250,729
Deposits and other assets                                                 3,183
                                                                     ----------
    Total other assets                                                  253,912
                                                                     ----------


TOTAL ASSETS                                                         $1,060,998
                                                                     ==========

                      LIABILITIES AND STOCKHOLDERS' DEFICIT

CURRENT LIABILITIES
Accounts payable and accrued expenses                                $  422,033
Due to related parties                                                  615,592
                                                                     ----------
   Total current liabilities                                          1,037,625
                                                                     ----------

LONG TERM LIABILITIES
Convertible debentures payable, net of discount of $871,316             458,992
Derivative liability                                                  1,985,372
Warrant liability                                                     1,009,437
                                                                     ----------
    Total current liabilities                                         3,453,801
                                                                     ----------

TOTAL LIABILITIES                                                     4,491,426
                                                                     ----------

COMMITMENTS AND CONTINGENCIES


         The accompanying notes are an integral part of these condensed
                       consolidated financial statements.

                                        2
<PAGE>

            MM2 GROUP, INC (F/K/A/ WIEN GROUP, INC.) AND SUBSIDIARIES
          CONDENSED CONSOLIDATED BALANCE SHEET (UNAUDITED) (CONTINUED)
                                DECEMBER 31, 2006


TEMPORARY EQUITY
Common stock: Class B - no par value, authorized 50,000,000
     shares; 10,000,000 shares issued and outstanding                       739
                                                                    -----------

STOCKHOLDERS' DEFICIT
Preferred stock, $1.00 par value; authorized 1,000,000 shares;
    no shares issued and outstanding                                       --
Common stock:
   Class A - no par value; authorized 450,000,000 shares;
       140,627,016 shares issued and outstanding                        731,505
   Class B - no par value; authorized 50,000,000 shares;
       10,000,000 shares issued and outstanding                             261
Additional paid-in capital                                              750,000
Accumulated deficit                                                  (4,912,933)
                                                                    -----------
   Total stockholders' deficit                                       (3,431,167)
                                                                    -----------

TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT                         $ 1,060,998
                                                                    -----------



         The accompanying notes are an integral part of these condensed
                       consolidated financial statements.

                                        3
<PAGE>

            MM2 GROUP, INC (F/K/A/ WIEN GROUP, INC.) AND SUBSIDIARIES
           CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
      FOR THE SIX MONTHS AND THREE MONTHS ENDED DECEMBER 31, 2006 AND 2005

<TABLE><CAPTION>
                                                    For the six months ended         For the three months ended
                                                           December 31,                      December 31,
                                                      2006             2005             2006             2005
                                                 -------------    -------------    -------------    -------------
<S>                                              <C>              <C>              <C>              <C>
SALES, net                                       $     426,276    $        --      $     400,135    $        --

COST OF SALES                                          154,254             --            147,522             --
                                                 -------------    -------------    -------------    -------------

GROSS PROFIT                                           272,022             --            252,613             --
                                                 -------------    -------------    -------------    -------------

GENERAL AND ADMINISTRATION
   EXPENSES
  Selling and marketing expenses                         7,500             --              7,500             --
General and administrative expenses                    582,189          371,549          360,820          196,593
  Depreciation expenses                                    443              443              221              221
                                                 -------------    -------------    -------------    -------------

  Total general and administration expenses            590,132          371,992          368,541          196,814
                                                 -------------    -------------    -------------    -------------

(LOSS) FROM OPERATIONS                                (318,110)        (371,992)        (115,928)        (196,814)
                                                 -------------    -------------    -------------    -------------

OTHER (INCOME) EXPENSES
    Other (income)                                     (49,320)         (14,715)          (3,710)          (6,513)
    Interest expense                                    62,129          115,278           33,531           57,639
    Liquidated damages                                  81,424          150,000           79,818           75,000
   Loss on revaluation of derivatives                  823,617             --            145,476             --
   Amortization of discount on debt conversion         290,439          500,000          145,220          250,000
    Write-off of deferred financing costs              369,625           40,192             --             40,192
                                                 -------------    -------------    -------------    -------------

  Total other (income) expenses                      1,577,914          790,755          400,335          416,318
                                                 -------------    -------------    -------------    -------------

(LOSS) BEFORE PROVISION FOR
  INCOME TAXES                                      (1,896,024)      (1,162,747)        (516,263)        (613,132)

PROVISION FOR INCOME TAXES                                --               --               --               --
                                                 -------------    -------------    -------------    -------------

NET (LOSS) APPLICABLE TO COMMON
    SHARES                                       $  (1,896,024)   $  (1,162,747)   $    (516,263)   $    (613,132)
                                                 =============    =============    =============    =============

NET (LOSS) PER COMMON SHARE
  Basic and diluted                              $       (0.01)   $       (0.01)   $       (0.00)   $       (0.00)
                                                 =============    =============    =============    =============

WEIGHTED AVERAGE SHARES OUTSTANDING
  Basic and diluted                                135,161,415      123,315,251      140,877,016      123,315,251
                                                 =============    =============    =============    =============
</TABLE>

         The accompanying notes are an integral part of these condensed
                       consolidated financial statements.

                                        4
<PAGE>

            MM2 GROUP, INC (F/K/A/ WIEN GROUP, INC.) AND SUBSIDIARIES
           CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
               FOR THE SIX MONTHS ENDED DECEMBER 31, 2006 AND 2005

<TABLE><CAPTION>
                                                                          2006           2005
                                                                      -----------    -----------
<S>                                                                   <C>            <C>
CASH FLOW FROM OPERATING ACTIVITIES
 Net (loss)                                                           $(1,896,024)   $(1,162,747)
 Adjustments to reconcile net (loss) to net cash (used in)
   operating activities
      Depreciation                                                            443            443
      Common stock issued for services                                     28,500           --
         Amortization of discount on debt conversion                      290,439        500,000
      Loss on revaluation of derivatives                                  823,617           --
      Gain on disposition of derivative liability                         (40,192)          --
         Write-off of financing costs                                     369,625         40,192
 Changes in operating assets and liabilities:
      Accounts receivable                                                 (49,355)          --
      Inventory                                                             4,209           --
      Prepaid expenses and other assets                                    71,022        (86,916)
Accounts payable and accrued liabilities                                  151,807        220,755
      Due to related parties                                              147,537        127,370
                                                                      -----------    -----------
 Total cash (used in) operating activities                                (98,372)      (360,903)
                                                                      -----------    -----------

CASH FLOWS FROM INVESTING ACTIVITIES
 Purchase of property and equipment                                        (1,146)          (556)
                                                                      -----------    -----------
 Total cash (used in) investing activities                                 (1,146)          (556)
                                                                      -----------    -----------

NET (DECREASE) IN CASH AND CASH EQUIVALENTS                               (99,518)      (361,459)

CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD                           504,598      1,034,799
                                                                      -----------    -----------

CASH AND CASH EQUIVALENTS - END OF PERIOD                             $   405,080    $   673,340
                                                                      ===========    ===========

SUPPLEMENTAL CASH FLOW INFORMATION Cash paid during the period for:
 Interest expense                                                     $      --      $    83,333
                                                                      ===========    ===========
 Income taxes                                                         $      --      $       --
                                                                      ===========    ===========
</TABLE>

         The accompanying notes are an integral part of these condensed
                       consolidated financial statements.

                                        5
<PAGE>

            MM2 GROUP, INC (F/K/A/ WIEN GROUP, INC.) AND SUBSIDIARIES
     CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) (CONTINUED)
               FOR THE SIX MONTHS ENDED DECEMBER 31, 2006 AND 2005


SUPPLEMENTAL SCHEDULE OF NON-CASH FINANCING AND INVESTING ACTIVITIES

For the six months ended December 31, 2006:
-------------------------------------------

Issued 1,849,689 shares of Class A common stock with a total value of $120,230,
which represents full satisfaction of the Commitment Shares under the Standby
Equity Distribution Agreement, pursuant to the Termination Agreement of July 20,
2006.

Issued 3,150,311 shares of Class A common stock with a total value of $204,770,
for Commitment Shares pursuant to the Amended and Restated Securities Purchase
Agreement of July 20, 2006.

Issued 600,000 shares of its Class A common stock with a total value of $18,000,
as compensation to Stephen Wien for services provided.

Issued 300,000 shares of its Class A common stock with a total value of $10,500,
as compensation for the consulting services with Allison Investment Corp. on
matters related to mergers and acquisitions.

Issued 1,411,765 shares of its Class A common stock with a total value of
$77,005, as compensation for the strategic alliance with UTEK Corporation to
identify synergistic technology acquisition opportunities in the future.

On September 21, 2006, the Company concluded the acquisition of Genotec
Nutritionals, Inc. Pursuant to the Asset Purchase Agreement, the Company issued
10,000,000 shares of Class A common stock valued at $300,000 to George
Kontonotas, Joseph Freedman, Susan Blancato, Michael Logerfo, Maureen
McLaughlin, Paula Daddone, Maureen Bridges and Robert Blancato. The net effect
on cash flows is as follows:

Accounts receivable                          $   179,002
Inventory                                         34,191
Prepaid expenses                                   2,149
Security deposit                                   3,183
Goodwill                                         250,729
Accounts payable and accrued expense            (169,254)
Common stock                                    (300,000)
                                             -----------
Total                                        $      --
                                             ===========


         The accompanying notes are an integral part of these condensed
                       consolidated financial statements.

                                        6
<PAGE>

            MM2 GROUP, INC (F/K/A/ WIEN GROUP, INC.) AND SUBSIDIARIES
     CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) (CONTINUED)
               FOR THE SIX MONTHS ENDED DECEMBER 31, 2006 AND 2005


SUPPLEMENTAL SCHEDULE OF NON-CASH FINANCING AND INVESTING ACTIVITIES

For the six months ended December 31, 2005:
-------------------------------------------

On June 24, 2005, the Company's Board of Directors declared a one-for-one stock
dividend of the common stock payable on July 29, 2005 to shareholders of record
as of July 11, 2005. The Company issued 3,689,636 shares.

On October 19, 2005, the Company issued a total of 115,933,332 shares of Class A
Common Stock and 10,000,000 shares of Class B Common Stock to Mr. Mahoney and
Mr. Meller pursuant to the terms of the Acquisition Agreement in exchange for
the outstanding shares of Old MM2's Class A Common Stock and Class B Common
Stock.






















         The accompanying notes are an integral part of these condensed
                       consolidated financial statements.

                                        7
<PAGE>

           MM2 GROUP, INC. (F/K/A/ WIEN GROUP, INC.) AND SUBSIDIARIES
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                                   (UNAUDITED)
                           DECEMBER 31, 2006 AND 2005

                                        9
NOTE 1 - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION

Description of business
-----------------------
MM2 Group, Inc. ("MM2", or the "Company"), was incorporated in New York on March
18, 1968 under the name John DeNegris Associates, Inc. In 1974, John DeNegris
Associates, Inc. changed its name to Wien Group, Inc. ("Wien (NY)"). Wien (NY)
conducted a public relations business and traded in the public market until
December 1991 when the corporation ceased operations. Wien (NY) remained
inactive until September 1998 when it reacquired its good standing status with
the State of New York. Wien (NY) did not conduct any business prior to July
2001, at which time it initiated its business of providing corporate financial
advisory services to small and emerging companies that require advisory services
to continue their growth within their respective industries. Wien (NY) primarily
focused on the manufacturing, retail, music & entertainment, and health care
industries. These services include: general corporate finance, merger and
acquisition advisory services, consulting on overall corporate strategy,
facilitating asset-based lending, and arranging equipment leasing contracts.

On September 23, 2005, Wien (NY) reincorporated in the state of New Jersey
pursuant to a Plan and Agreement of Merger. Pursuant to such Plan and Agreement
of Merger, Wien (NY) merged with and into its wholly owned subsidiary ("Wien
(NJ)") with Wien (NJ) being the surviving entity. Wien (NJ)'s charter provided
for the authorization of Class A Common Stock (the "Wien (NJ) Class A Common"),
Class B Common Stock ("Wien (NJ) Class B Common"), and Preferred Stock ("Wien
(NJ) Preferred"). Pursuant to the Plan and Agreement of Merger, each holder of
Wien (NY)'s Common Stock received one share of Wien (NJ) Class A Common in
exchange for each share of such holder's Common Stock.

On October 12, 2005, Wien (NJ)'s name was changed to MM2 Group, Inc.

On October 19, 2005, Wien (NJ) completed its previously disclosed acquisition
(the "Acquisition") of all of the outstanding shares of MM2 Group, Inc., a New
Jersey corporation ("OldMM2"). The Acquisition was effected pursuant to the
terms of the Acquisition Agreement dated July 8, 2005 (the "Acquisition
Agreement") between Wien (NY), Wien (NJ), Stephen Wien, OldMM2 and the
stockholders of OldMM2 as of the date of the Acquisition Agreement. Prior to the
closing of the Acquisition, certain terms and conditions of the Acquisition
Agreement were amended by the parties thereto. The primary changes were to (i)
allow fractional shares of Wien (NJ) to be issued in connection with the
Acquisition (ii) correctly state the authorized capital stock of Wien (NJ) and
Wien (NY) and (iii) specify the authorized stock of Wien (NJ) following the
reincorporation.

The Company had nominal operations immediately before and after the Acquisition.
OldMM2 was a corporation formed on December 8, 2004. Other than the Acquisition,
no significant business activity has been conducted by OldMM2 from the date of
its creation to the date of the consummation of the Acquisition. The primary
activity of OldMM2 involved seeking merger or acquisition candidates with whom
it could either merge or acquire.

The Company is publicly traded and is currently traded on the NASD Over The
Counter Bulletin Board ("OTCBB") under the symbol "MMGP".

                                        8
<PAGE>

           MM2 GROUP, INC. (F/K/A/ WIEN GROUP, INC.) AND SUBSIDIARIES
        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                                   (UNAUDITED)
                           DECEMBER 31, 2006 AND 2005

NOTE 1 - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (CONTINUED)

Basis of presentation
---------------------
The acquisition was accounted for as a reverse merger under the purchase method
of accounting. Accordingly, MM2 Group, Inc. will be treated as the continuing
entity for accounting purposes. The accompanying financial statements include
the accounts of Old MM2, Wien (NY) and its wholly owned subsidiary Wien (NJ).
These condensed consolidated financial statements have been prepared in
accordance with accounting principles generally accepted in the United States
for financial information and with the instructions to Form 10-QSB and
Regulation S-B. Accordingly, they do not include all of the information and
footnotes required by generally accepted accounting principles for complete
financial statements. In the opinion of management, all adjustments (consisting
only of normal recurring adjustments) considered necessary for a fair
presentation have been included. It is suggested that these condensed
consolidated financial statements be read in conjunction with the June 30, 2006
audited financial statements and the accompanying notes thereto filed with the
Securities and Exchange Commission on Form 10-KSB.

On September 21, 2006, the Company completed the acquisition of Genotec
Nutritionals, Inc, a New York based manufacturer and distributor of nutritional
supplements and vitamins. Pursuant to the Asset Purchase Agreement, the Company
issued 10,000,000 shares of Class A common stock valued at $300,000 to George
Kontonotas, Joseph Freedman, Susan Blancato, Michael Logerfo, Maureen
McLaughlin, Paula Daddone, Maureen Bridges and Robert Blancato. In addition, the
Company executed three-year employment agreements with Mr. Kontonotas, Mr.
Freedman and Ms Blancato and purchased $75,000 of Genotec's Series A Convertible
Preferred Stock which was used to fund the working capital.

The result of operations for the six months ending December 31, 2006 and 2005,
are not necessarily indicative of the results to be expected for the full year.
For further information, refer to the financial statements and footnotes
included in Form 10-KSB for the year ended June 30, 2006. References to the
"Company," "we," "us" and "our" refer to MM2 Group Inc.

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Principles of Consolidation
---------------------------
The accompanying condensed consolidated financial statements include the
accounts of the Company and its wholly owned subsidiaries. All significant
inter-company transactions and accounts have been eliminated in consolidation.

Use of Estimates
----------------
The preparation of financial statements in conformity with accounting principles
generally accepted in the United States of America requires management to make
estimates and assumptions that affect the reported amounts of assets and
liabilities and disclosure of contingent assets and liabilities at the date of
the financial statements and the reported amounts of revenue and expenses during
the reporting period. Actual results could differ from those estimates.

                                        9
<PAGE>

           MM2 GROUP, INC. (F/K/A/ WIEN GROUP, INC.) AND SUBSIDIARIES
        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                                   (UNAUDITED)
                           DECEMBER 31, 2006 AND 2005

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Cash and Cash Equivalents
-------------------------
The Company considers all highly liquid investments purchased with original
maturities of six months or less to be cash equivalents. The Company had cash
equivalents at December 31, 2006 of $233,218. The cash equivalents represent
investments in Triple A credit rated money market funds that have 7-day auction
rates competitive with current market conditions.

Concentration of Credit Risk
----------------------------
The Company places its cash in what it believes to be credit-worthy financial
institutions. However, cash balances may exceed FDIC insured levels at various
times during the year. The Company has uninsured cash balances at December 31,
2006 of $322,413.

Revenue Recognition
-------------------
The Company recognizes revenues when products are shipped from their warehouse
or when the Company is notified that product has been drop-shipped from the
suppliers.

Accounts Receivables
--------------------
Accounts receivables consist primarily of uncollected invoices for product
sales. Payment terms vary from customer to customer and range from "payment on
delivery" to "60 days" terms. The Company does not provide for customer returns,
but will accommodate customers in special circumstances.

Inventory
---------
Inventory consists primarily of bulk supplies of capsules and sealed powders,
bottles, caps and shipping containers. Finished product is bottled and packaged
immediately before delivery.

Property and Equipment
----------------------
Property and equipment is stated at cost. Depreciation is computed using the
straight-line method based upon the estimated useful lives of the assets,
generally five to seven years. Maintenance and repairs are charged to expense as
incurred.

Financing Costs
---------------
Financing costs consist primarily of commitment fees and broker fees relating to
the issuance of the Company's convertible debentures. These costs are generally
capitalized and amortized over the term of the debenture. In some cases, these
fees are expensed immediately if they relate to expired or terminated
debentures.

Goodwill and Other Intangible Assets
------------------------------------
In September 2001, the FASB issued Statement No. 142 "Goodwill and Other
Intangible Assets". This statement addresses financial accounting and reporting
for acquired goodwill and other intangible assets and supersedes APB Opinion No.
17, Intangible Assets. It addresses how intangible assets that are acquired
individually or with a group of

                                       10
<PAGE>

           MM2 GROUP, INC. (F/K/A/ WIEN GROUP, INC.) AND SUBSIDIARIES
        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                                   (UNAUDITED)
                           DECEMBER 31, 2006 AND 2005

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Goodwill and Other Intangible Assets (Continued)
------------------------------------------------
other assets (but not those acquired in a business combination) should be
accounted for in financial statements upon their acquisition. This Statement
also addresses how goodwill and other intangible assets should be accounted for
after they have been initially recognized in the financial statements. The
Company recorded $250,729 in goodwill in its acquisition of Genotec
Nutritionals, Inc. Goodwill is tested for impairment annually.

Income Taxes
------------
The Company accounts for income taxes in accordance with Statements of Financial
Accounting Standards No. 109, "Accounting for Income Taxes," which requires an
asset and liability approach to financial accounting and reporting for income
taxes. Deferred income taxes and liabilities are computed annually for
differences between the financial statement and the tax basis of assets and
liabilities that will result in taxable or deductible amounts in the future
based on enacted tax laws and rates applicable to the periods in which the
differences are expected to affect taxable income. Valuation allowances are
established when necessary to reduce deferred tax assets to the amount expected
to be realized.

Share-Based Payment
-------------------
On December 16, 2004, the Financial Accounting Standards Board ("FASB")
published Statement of Financial Accounting Standards No. 123 (Revised 2004),
Share-Based Payment ("SFAS 123R"). SFAS 123R requires that compensation cost
related to share-based payment transactions be recognized in the financial
statements. Share-based payment transactions within the scope of SFAS 123R
include stock options, restricted stock plans, performance-based awards, stock
appreciation rights, and employee share purchase plans. The provisions of SFAS
123R are effective for small business issuers as of the first interim period
that begins after December 15, 2005. Accordingly, the Company has implemented
the revised standard in the quarter ending December 31, 2005. The adoption of
FAS 123R has not had any effect on the financial statements of the Company.

The Company measures compensation expense for its non-employee stock-based
compensation under the Financial Accounting Standards Board (FASB) Emerging
Issues Task Force (EITF) Issue No. 96-18, "ACCOUNTING FOR EQUITY INSTRUMENTS
THAT ARE ISSUED TO OTHER THAN EMPLOYEES FOR ACQUIRING, OR IN CONJUNCTION WITH
SELLING, GOODS OR SERVICES". The fair value of the option issued is used to
measure the transaction, as this is more reliable than the fair value of the
services received. Fair value is measured as the value of the Company's common
stock on the date that the commitment for performance by the counterparty has
been reached or the counterparty's performance is complete. The fair value of
the equity instrument is charged directly to compensation expense and additional
paid-in capital.

                                       11
<PAGE>

           MM2 GROUP, INC. (F/K/A/ WIEN GROUP, INC.) AND SUBSIDIARIES
        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                                   (UNAUDITED)
                           DECEMBER 31, 2006 AND 2005

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Basic and Diluted Earnings Per Common Share
-------------------------------------------
SFAS No. 128, "Earnings Per Share" requires presentation of basic earnings per
share ("basic EPS") and diluted earnings per share ("diluted EPS").

The computation of basic EPS is computed by dividing income (loss) available to
common stockholders by weighted average number of common shares during the
period. Diluted earnings per share gives effect to all dilutive potential common
shares outstanding during the period. The computation of diluted EPS does not
assume conversion, exercise, or contingent exercise of securities that would
have an anti-dilutive effect on earnings resulting from the Company's net loss
position.

On June 24, 2005, the Company's Board of Directors declared a 1 for 1 stock
dividend whereby, on July 29, 2005, each holder of record of common stock as of
July 11, 2005, would receive one additional share of common stock for each share
then held. For purposes of calculating the weighted average shares outstanding
used in the earnings per share calculation, the stock dividend has been
retroactively applied for the six months ended December 31, 2005.

On October 19, 2005, the Company issued 115,933,332 shares of Class A Common
stock to shareholders of Old MM2 pursuant to the terms of the Acquisition
Agreement. For purposes of calculating the weighted average shares outstanding
used in the earnings per share calculation, these shares have been retroactively
applied for the six months ended December 31, 2005.

The shares used in the computations are as follows:
<TABLE><CAPTION>
                                          For the six months         For the three months
                                          Ended December 31,           Ended December 31,
                                          2006          2005          2006           2005
                                      -------------------------   -------------------------
<S>                                   <C>           <C>           <C>           <C>
Average shares outstanding for
Basic and diluted earnings per share  135,161,415   123,315,251   140,877,016   123,315,251
                                      ===========   ===========   ===========   ===========
</TABLE>

The Company had common stock equivalents of 20,750,000 and 750,000 at December
31, 2006 and 2005, respectively.

Derivative Liabilities
----------------------
During April 2003, the Financial Accounting Standards Board issued SFAS 149,
"Amendment of Statement 133 on Derivative Instruments and Hedging Activities."
SFAS 149 amends and clarifies accounting for derivative instruments, including
certain derivative instruments embedded in other contracts, and for hedging
activities under SFAS 133, "Accounting for Derivative Instruments and Hedging
Activities." The statement requires that contracts with comparable
characteristics be accounted for similarly and clarifies when a derivative
contains a financing component that warrants special reporting in the statement
of cash flows. SFAS 149 is effective for contracts entered into or modified
after June 30, 2003, except in certain circumstances, and for hedging

                                       12
<PAGE>

           MM2 GROUP, INC. (F/K/A/ WIEN GROUP, INC.) AND SUBSIDIARIES
        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                                   (UNAUDITED)
                           DECEMBER 31, 2006 AND 2005

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Derivative Liabilities (Continued)
----------------------------------

relationships designated after June 30, 2003. The financial statements for the
six months ended December 31, 2006 include the recognition of the derivative
liability on the underlying securities issuable upon conversion of the Cornell
Convertible Debentures.

Recent Accounting Pronouncement
-------------------------------
On December 16, 2004, the Financial Accounting Standards Board ("FASB")
published Statement of Financial Accounting Standards No. 123 (Revised 2004),
Share-Based Payment ("SFAS 123R"). SFAS 123R requires that compensation cost
related to share-based payment transactions be recognized in the financial
statements. Share-based payment transactions within the scope of SFAS 123R
include stock options, restricted stock plans, performance-based awards, stock
appreciation rights, and employee share purchase plans. The provisions of SFAS
123R are effective for small business issuers as of the first interim period
that begins after December 15, 2005. Accordingly, the Company implemented the
revised standard in the first quarter of fiscal year 2006. The Company issued
warrants during the reporting periods, and as such, applied FAS 123R and EITF
96-18 in reporting these transactions on the Company's financial statements.

In December 2004, the Financial Accounting Standards Board ("FASB") issued
Statement of Financial Accounting Standards ("SFAS") No. 151, "Inventory Costs."
SFAS No. 151 requires abnormal amounts of inventory costs related to idle
facility, freight handling and wasted material expenses to be recognized as
current period charges. Additionally, SFAS No. 151 requires that allocation of
fixed production overheads to the costs of conversion be based on the normal
capacity of the production facilities. The standard is effective for fiscal
years beginning after June 15, 2005. The adoption of SFAS No. 151 did not have
an impact on the Company's financial position or results of operations.

In May 2005, the FASB issued SFAS No. 154, "Accounting Changes and Error
Corrections." SFAS No. 154 replaces Accounting Principles Board ("APB") Opinion
No. 20, "Accounting Changes" and SFAS No. 3, "Reporting Accounting Changes in
Interim Financial Statements." SFAS No. 154 requires retrospective application
to prior periods' financial statements of a voluntary change in accounting
principle unless it is impracticable. APB No. 20 previously required that most
voluntary changes in accounting principle be recognized by including the
cumulative effect of changing to the new accounting principle in net income in
the period of the change. SFAS No. 154 is effective for accounting changes and
corrections of errors made in fiscal years beginning after December 15, 2005.
The adoption of SFAS No. 154 did not have an impact on the Company's financial
position or results of operations.

                                       13
<PAGE>

           MM2 GROUP, INC. (F/K/A/ WIEN GROUP, INC.) AND SUBSIDIARIES
        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                                   (UNAUDITED)
                           DECEMBER 31, 2006 AND 2005

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

In February 2006, the FASB issued SFAS No. 155, "Accounting for Certain Hybrid
Financial Instruments, an amendment of FASB Statements No. 133 and 140." SFAS
No. 155 resolves issues addressed in SFAS No. 133 Implementation Issue No. D1,
"Application of Statement 133 to Beneficial Interests in Securitized Financial
Assets," and permits fair value remeasurement for any hybrid financial
instrument that contains an embedded derivative that otherwise would require
bifurcation, clarifies which interest-only strips and principal-only strips are
not subject to the requirements of SFAS No. 133, establishes a requirement to
evaluate interests in securitized financial assets to identify interests that
are freestanding derivatives or that are hybrid financial instruments that
contain an embedded derivative requiring bifurcation, clarifies that
concentrations of credit risk in the form of subordination are not embedded
derivatives and amends SFAS No. 140 to eliminate the prohibition on a qualifying
special-purpose entity from holding a derivative financial instrument that
pertains to a beneficial interest other than another derivative financial
instrument. SFAS No. 155 is effective for all financial instruments acquired or
issued after the beginning of the first fiscal year that begins after September
15, 2006. The Company is currently evaluating the effect the adoption of SFAS
No. 155 will have on its financial position or results of operations.


In March 2006, the FASB issued SFAS No. 156, "Accounting for Servicing of
Financial Assets", an amendment of FASB Statement No. 140. SFAS No. 156 requires
an entity to recognize a servicing asset or liability each time it undertakes an
obligation to service a financial asset by entering into a servicing contract
under a transfer of the servicer's financial assets that meets the requirements
for sale accounting, a transfer of the servicer's financial assets to a
qualified special-purpose entity in a guaranteed mortgage securitization in
which the transferor retains all of the resulting securities and classifies them
as either available-for-sale or trading securities in accordance with SFAS No.
115, "Accounting for Certain Investments in Debt and Equity Securities" and an
acquisition or assumption of an obligation to service a financial asset that
does not relate to financial assets of the servicer or its consolidated
affiliates. Additionally, SFAS No. 156 requires all separately recognized
servicing assets and servicing liabilities to be initially measured at fair
value, permits an entity to choose either the use of an amortization or fair
value method for subsequent measurements, permits at initial adoption a one-time
reclassification of available-for-sale securities to trading securities by
entities with recognized servicing rights and requires separate presentation of
servicing assets and liabilities subsequently measured at fair value and
additional disclosures for all separately recognized servicing assets and
liabilities. SFAS No. 156 is effective for transactions entered into after the
beginning of the first fiscal year that begins after September 15, 2006. The
Company is currently evaluating the effect the adoption of SFAS No. 156 will
have on its financial position or results of operations.

                                       14
<PAGE>

           MM2 GROUP, INC. (F/K/A/ WIEN GROUP, INC.) AND SUBSIDIARIES
        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                                   (UNAUDITED)
                           DECEMBER 31, 2006 AND 2005

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

In September 2006, The Financial Accounting Standards Board ("FASB") issued
Statement of Financial Accounting Standards ("SFAS") No. 157, "Fair Value
Measurement" ("SFAS No. 157"). This standard provides guidance for using fair
value to measure assets and liabilities. SFAS No. 157 applies whenever other
standards require (or permit) assets or liabilities to be measured at fair value
but does not expand the use of fair value in any new circumstances. Prior to
SFAS No. 157, the methods for measuring fair value were diverse and
inconsistent, especially for items that are not actively traded. The standard
clarifies that for items that are not actively traded, such as certain kinds of
derivatives, fair value should reflect the price in a transaction with a market
participant, including an adjustment for risk, not just the company's
mark-to-model value. SFAS No. 157 also requires expanded disclosure of the
effect on earnings for items measured using unobservable data. SFAS No. 157 is
effective for financial statements issued for fiscal years beginning after
November 15, 2007, and interim periods within those fiscal years. The Company is
currently evaluating the impact of this statement on its financial statements
and expects to adopt SFAS No.157 on December 31, 2007.

In September 2006, the FASB issued SFAS No. 158, "Employers' Accounting for
Defined Benefit Pension and Other Postretirement Plans -- An Amendment of FASB
Statements No. 87, 88, 106, and 132R." This standard requires an employer to:
(a) recognize in its statement of financial position an asset for a plan's
overfunded status or a liability for a plan's underfunded status; (b) measure a
plan's assets and its obligations that determine its funded status as of the end
of the employer's fiscal year (with limited exceptions); and (c) recognize
changes in the funded status of a defined benefit postretirement plan in the
year in which the changes occur. Those changes will be reported in comprehensive
income. The requirement to recognize the funded status of a benefit plan and the
disclosure requirements are effective as of the end of the fiscal year ending
after December 15, 2006. The requirement to measure plan assets and benefit
obligations as of the date of the employer's fiscal year-end statement of
financial position is effective for fiscal years ending after December 15, 2008.
The adoption of FAS 158 is not anticipated to have a material impact on the
Company's financial position or results of operations.

                                       15
<PAGE>

           MM2 GROUP, INC. (F/K/A/ WIEN GROUP, INC.) AND SUBSIDIARIES
        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                                   (UNAUDITED)
                           DECEMBER 31, 2006 AND 2005

NOTE 3 - GOODWILL

On September 21, 2006, the Company concluded the acquisition of Genotec
Nutritionals, Inc. Pursuant to the Asset Purchase Agreement, the Company issued
10,000,000 shares of Class A common stock valued at $300,000 to George
Kontonotas, Joseph Freedman, Susan Blancato, Michael Logerfo, Maureen
McLaughlin, Paula Daddone, Maureen Bridges and Robert Blancato. The calculation
of Goodwill is as follows:

   Common stock issued                                 $  300,000
   Plus liabilities assumed:
      Accounts payable and accrued expense                169,254
                                                       ----------
      Total purchase price                                469,254

   Less assets acquired:
      Accounts receivable                                 179,002
      Inventory                                            34,191
      Prepaid expenses                                      2,149
      Security deposit                                      3,183
                                                       ----------
   Total Goodwill                                      $  250,729
                                                       ==========

NOTE 4 - INCOME TAXES

 Deferred tax assets and liabilities reflect the net tax effect of temporary
differences between the carrying amount of assets and liabilities for financial
reporting purposes and amounts used for income tax purposes. Significant
components of the Company's deferred tax assets and liabilities are summarized
as follows:
                                                       At December 31,
                                                            2006
                                                       --------------
         Deferred tax asset                              $ 1,666,000
         Less:  Valuation allowance                       (1,666,000)
                                                         -----------
         Net deferred tax assets                         $      --
                                                         ===========

As of December 31, 2006, the Company has net operating loss carry forwards of
approximately $4,900,000 that can be utilized to offset future taxable income
for Federal income tax purposes through 2026. Utilization of these net loss
carry forwards is subject to the limitations of Internal Revenue Code Section
382. Because of the current uncertainty of realizing the benefit of the tax
carry forward, a valuation allowance equal to the tax benefit for deferred taxes
has been established. The full realization of the tax benefit associated with
the carry forward depends predominantly upon the Company's ability to generate
taxable income during the carry forward period.

                                       16
<PAGE>

           MM2 GROUP, INC. (F/K/A/ WIEN GROUP, INC.) AND SUBSIDIARIES
        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                                   (UNAUDITED)
                           DECEMBER 31, 2006 AND 2005

NOTE 5 - RELATED PARTY TRANSACTIONS

As of December 31, 2006, the Company has accrued $615,592 of deferred
compensation for the Non-executive Chairman and the President of the Company.
These deferrals will remain unpaid until the Board of Directors determines that
the Company has sufficient liquidity to make such payments. The Non-executive
Chairman and the President of the Company have further agreed, however, to
accept payment or partial payment, from time to time, in the form of the
Company's Class A Common Stock and/or the Company's Class B Company Stock, at
such time as the Board of Directors determines to issue such shares in
satisfaction of these accrued liabilities.

NOTE 6 - CONVERTIBLE DEBENTURES PAYABLE

On April 1, 2005, we entered into a Securities Purchase Agreement with Cornell
for the sales of $2,500,000 of secured convertible debentures. The agreement was
amended and restated on July 20, 2006 and January 4, 2007 to reflect the change
in the funding formulas. Pursuant to the terms of the agreement with Cornell, on
April 1, 2005 we issued a secured convertible debenture in the principal amount
of $1,250,000. On July 20, 2006, the secured convertible debenture was amended
and restated and reissued in an aggregate principal amount of $1,330,308, which
included accrued and unpaid interest on the original convertible debenture of
$80,308. Interest on the outstanding principal balance of the Secured
Convertible Debentures accrues at the annual rate of 10%. Payment of principal
and accrued interest shall be paid on or before July 1, 2008 on the July 20,
2006 debenture. The Company has the option to redeem a portion or all of the
outstanding debentures at 120% of the amount redeemed plus accrued interest. The
holder shall be entitled to convert in whole or in part at any time and from
time to time, any amount of principal and accrued interest at a price equal to
90% of the lowest closing bid price of the Common Stock during the 30 trading
days immediately preceding the conversion date, as quoted by Bloomberg, LP
("Conversion Price").

In the event of a default, the full principal amount of this Debenture, together
with interest and other amounts owing, shall be due and payable in cash,
provided however, the holder of the debenture may request payment of such
amounts in Common Stock of the Obligor at the Conversion Price then in-effect. A
holder of the debenture may not convert this Debenture or receive shares of
Common Stock as payment of interest hereunder to the extent such conversion or
receipt of such interest payment would result in the holder of the debenture
beneficially owning in excess of 4.9% of the then issued and outstanding shares
of Common Stock, including shares issuable upon conversion of, and payment of
interest on, this Debenture.

                                       17
<PAGE>

           MM2 GROUP, INC. (F/K/A/ WIEN GROUP, INC.) AND SUBSIDIARIES
        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                                   (UNAUDITED)
                           DECEMBER 31, 2006 AND 2005

NOTE 6 - CONVERTIBLE DEBENTURES PAYABLE (CONTINUED)

Upon execution of the above agreements, the Company issued to Cornell 1,849,689
shares of Class A common stock, in accordance with the Termination Agreement of
July 20, 2006, and another certificate for 3,150,311 shares of Class A common
stock, for the aggregate total of 5,000,000 shares of Common Stock
(collectively, the "Commitment Shares").

The aggregate principal value of the Amended and Restated Secured Convertible
Debenture is $1,330,308. This amount is shown net of the unamortized portion of
the discount on conversion of $871,316. This discount is being amortized over
the life of the debenture and is being recorded as a charge to amortization of
discount on debt conversion on the statement of operations.

NOTE 7 - DERIVATIVE LIABILITY

In accordance with SFAS 133, "Accounting for Derivative Instruments and Hedging
Activities" and EITF 00-19, "Accounting for Derivative Financial Instruments
Indexed to, and Potentially Settled in, a Company's Own Stock", the conversion
feature associated with the Cornell Secured Convertible Debentures represents
embedded derivatives. As such, the Company had recognized embedded derivatives
in the amount of $1,161,755 as a liability in the accompanying condensed
consolidated balance sheet, and it is now measured at its estimated fair value
of $1,985,372. The estimated fair value of the embedded derivative has been
calculated based on a Black-Scholes pricing model using the following
assumptions:

         Fair market value of stock                                  $0.030
         Lowest closing bid price last 30 trading days               $0.020
         Exercise price                                              $0.018
         Dividend yield                                                0.00%
         Risk free interest rate                                       5.60%
         Expected volatility                                         239.44%
         Expected life                                             1.5 Years

                                       18
<PAGE>

           MM2 GROUP, INC. (F/K/A/ WIEN GROUP, INC.) AND SUBSIDIARIES
        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                                   (UNAUDITED)
                           DECEMBER 31, 2006 AND 2005

NOTE 8 - TEMPORARY EQUITY

As of December 31, 2006, the Company does not have sufficient quantity of
authorized Class A common stock to meet it potential obligations for conversions
of the Class B common stock, the Cornell Secured Convertible Debentures and the
Cornell Warrants. The Class B common stock is convertible into approximately 667
million shares of Class A common stock. The Cornell Secured Convertible
Debentures are convertible into approximately 74 million shares of Class A
common stock. The Cornell Warrants are convertible into approximately 21 million
shares of Class A common stock. The accounts due to related parties are
convertible into approximately 41 million shares of Class A common stock. The
aggregate amount of shares outstanding and those due upon these conversions is
in excess of 943 million, which exceeds the 450 million authorized in the
Certificate of Incorporation. As such, this account has been reclassified to
temporary equity until the situation can be resolved. Management intends to
remedy this situation by increasing the number of authorized shares with the
consent of the shareholders, or, alternatively, seeking a written forbearance
from the holders of the Class B Common Stock whereby those holders will consent
to not converting their Class B Common Stock to Class A Common Stock unless and
until there is sufficient Class A Common Stock authorized by the Corporation to
honor such conversion.

NOTE 9 - STOCKHOLDERS' DEFICIT

In accordance with its Certificate of Incorporation as filed on July 7, 2005,
the Company is authorized to issue 1,000,000 shares of Preferred stock, $1.00
par value, 450,000,000 shares of Class A common stock, no par value; and
50,000,000 shares of Class B Common Stock, no par value.

PREFERRED STOCK

Preferred Stock consists of 1,000,000 shares of authorized preferred stock with
$1.00 par value. As of December 31, 2006, no shares were issued or outstanding.

CLASS A COMMON STOCK

Class A Common Stock consists of the following as of December 31, 2006:
450,000,000 shares of authorized common stock with no par value, 140,627,016
shares were issued and outstanding. Each holder of Class A common stock is
entitled to receive ratably dividends, if any, as may be declared by the Board
of Directors out of funds legally available for the payment of dividends. The
Company has never paid any dividends on its common stock and does not
contemplate doing so in the foreseeable future. The Company anticipates that any
earnings generated from operations will be used to finance the growth
objectives.

                                       19
<PAGE>

           MM2 GROUP, INC. (F/K/A/ WIEN GROUP, INC.) AND SUBSIDIARIES
        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                                   (UNAUDITED)
                           DECEMBER 31, 2006 AND 2005

NOTE 9 - STOCKHOLDERS' DEFICIT (CONTINUED)

For the six months ended December 31, 2006, the Company had the following
transactions in its Class A common stock:

     On July 20, 2006, the Company issued 1,849,689 shares of Class A common
     stock with a total value of $120,230, which represents full satisfaction of
     the Commitment Shares under the Standby Equity Distribution Agreement,
     pursuant to the Termination Agreement of July 20, 2006.

     On July 20, 2006, the Company issued 3,150,311 shares of Class A common
     stock with a total value of $204,770, for Commitment Shares pursuant to the
     Amended and Restated Securities Purchase Agreement of July 20, 2006.

     On August 10, 2006, the Company issued 1,411,765 shares of its Class A
     common stock with a total value of $77,005, as compensation for the
     strategic alliance with UTEK Corporation to identify synergistic technology
     acquisition opportunities in the future.

     On September 5, 2006, the Company issued 600,000 shares of its Class A
     common stock with a total value of $18,000, as compensation to Stephen Wien
     for services provided.

     On September 21, 2006, the Company concluded the acquisition of Genotec
     Nutritionals, Inc. Pursuant to the Asset Purchase Agreement, the Company
     issued 10,000,000 shares of Class A common stock valued at $300,000 to
     George Kontonotas, Joseph Freedman, Susan Blancato, Michael Logerfo,
     Maureen McLaughlin, Paula Daddone, Maureen Bridges and Robert Blancato.

     On October 6, 2006, the Company issued 300,000 shares of its Class A common
     stock with a total value of $10,500, as compensation for the consulting
     services with Allison Investment Corp. on matters related to mergers and
     acquisitions.

CLASS B COMMON STOCK

As of December 31, 2006, Class B Common Stock consisted of 50,000,000 shares of
authorized common stock with no par value, 10,000,000 shares were issued and
outstanding. Class B stock has voting rights of 100 to 1 with respect to Class A
Common Stock. Class B common stockholders are entitled to receive dividends in
the same proportion as the Class B Common Stock conversion and voting rights
have to Class A Common Stock. A holder of Class B Common Stock has the right to
convert each share of Class B Common Stock into the number of shares of Class A
Common Stock determined by dividing the number of Class B Common Stock being
converted by a 50% discount of the lowest price that the Company had ever issued
its Class A Common Stock. Upon the liquidation, dissolution, or winding-up of
the Company, holders of Class B Common Stock will be entitled to receive
distributions.

                                       20
<PAGE>

           MM2 GROUP, INC. (F/K/A/ WIEN GROUP, INC.) AND SUBSIDIARIES
        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                                   (UNAUDITED)
                           DECEMBER 31, 2006 AND 2005

NOTE 10 - WARRANTS

On April 1, 2005, the Company sold to Cornell Capital a warrant to purchase
750,000 shares of its common stock for a purchase price of $10. This warrant had
an exercise price of $.07 per shares, was vested immediately and expires two
years from the date of issue. On July 20, 2006, the Company issued an Amended
and Restated warrant which changed the exercise price to $.05 per share and
extended the redemption period to five years from the date of issuance. The fair
value of the amended warrant of $44,625 was estimated using the Black-Scholes
option-pricing model with the following weighted-average assumptions: dividend
yield of 0%; expected volatility of 142.21%; risk-free interest rates of 4.60%;
and expected life of 5 years. The gain on the disposition of the initial warrant
was credited to other income for $40,192. The expense for the amended warrant of
$44,625 was charged to financing costs.

NOTE 11 - COMMITMENTS AND CONTINGENCIES

The Company entered into two employment agreements with Jerome Mahoney, its
Non-executive Chairman of the Board and Mark Meller, its President and Board
Member, as of December 15, 2004. Each of the employment agreements is for a term
through March 31, 2011 and provides for annual compensation of $200,000 with an
annual increase of 10%. In addition, each executive shall be entitled to Company
sponsored fringe benefits and annual bonuses in accordance with the Company
policies and plans in effect for Executive officers of the Company. The
executives shall also be granted stock options under the Company's stock option
plan as adopted by the Board of Directors and the shareholders of the Company.
The executives will each receive a $750,000 bonus for the successful completion
of the registration of the Company's stock on Form S-1, SB-2 and any other such
form of registration statement declared effective by the Securities and Exchange
Commission. This bonus shall be paid in a lump sum on the date the registration
statement is declared effective, or alternately, at the discretion of the
Company and with the agreement of the Executive, in shares of the Company's
Class B Common Stock.

On October 1, 2006, the Company entered into a sub-lease with SWK Technologies,
Inc. for an office located at 5 Regent Street, Suite 520, Livingston, NJ 07052.
The rent is on a month-to-month basis for $350 per month SWK Technologies, Inc.
is a wholly-owned subsidiary of Trey Resources, Inc. We use our these facilities
to house our corporate headquarters and operations and believe our facilities
are suitable for such purpose.

On February 1, 2005, our wholly owned subsidiary, Genotec Nutritionals amended
its operating lease for office and warehouse space at 450 Commack Road, Deer
Park, NY. The term of the lease is four years commencing March 1, 2005. Monthly
base rental payments under the new lease range from $3,067 to $3,354 per month.
We are required to pay property taxes, utilities, insurance and other costs
relating to the leased facilities to include allocated common area maintenance
charges, snow removal charges and landlord insurance charges as deemed
necessary.

                                       21
<PAGE>

           MM2 GROUP, INC. (F/K/A/ WIEN GROUP, INC.) AND SUBSIDIARIES
        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                                   (UNAUDITED)
                           DECEMBER 31, 2006 AND 2005

NOTE 12 - GOING CONCERN

The accompanying condensed consolidated financial statements have been prepared
in conformity with accounting principles generally accepted in the United States
of America, which contemplates continuation of the Company as a going concern.

The Company has suffered recurring losses and experiences a deficiency of cash
flow from operations. These matters raise substantial doubt about the Company's
ability to continue as a going concern. The recoverability of a major portion of
the recorded asset amounts shown in the accompanying condensed consolidated
balance sheet is dependent upon continued operations of the Company, which in
turn, is dependent upon the Company's ability to raise capital and/or generate
positive cash flows from operations.

The Company is actively evaluating business combinations, through mergers or
acquisitions that will provide sales growth potential and positive cash flows.
As an example, on September 21, 2006, the Company completed the acquisition of
Genotec Nutritionals, Inc, a New York based manufacturer and distributor of
nutritional supplements and vitamins. Management believes that this is an
excellent opportunity to enter into the Nutraceuticals Market by acquiring an
existing company with an established customer base.

These condensed consolidated financial statements do not include any adjustments
relating to the recoverability and classification of recorded assets, or the
amounts and classification of liabilities that might be necessary in the event
the Company cannot continue in existence.

NOTE 13 - SUBSEQUENT EVENTS

On January 12, 2007, the Company issued 3,086,420 shares of its Class A Common
Stock to Cornell Capital Partners upon conversion of $50,000 of the secured
convertible debentures.

                                       22
<PAGE>

ITEM 2 - MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION

         You should read the following discussion in conjunction with our
financial statements and related notes included elsewhere in this filing as well
as our audited statements and related notes for the fiscal year ended June 30,
2006 filed with Form 10-KSB. The following discussion contains forward-looking
statements. Please see "Forward Looking Statements - Cautionary Factors" for a
discussion of uncertainties, risks and assumptions associated with these
statements

PLAN OF OPERATION

         On September 21, 2006, the Company completed the acquisition Genotec
Nutritionals, Inc., a distributor and marketer of nutritional supplements and
vitamins. The Company intends to develop businesses in the nutraceutical market
via internal growth and product development, and by acquisition of other
companies that operate in that market. The Company does retain the right and
flexibility, however, to complete acquisition or merger transactions in other
markets or industries.

         The Company has a limited operating history on which to base an
evaluation of its business and prospects. Its prospects must be considered in
light of the risks, expenses and difficulties frequently encountered by
companies in their early stage of development, particularly companies in new and
rapidly evolving markets. The Company will encounter various risks in
implementing and executing its business strategy. The Company can provide no
assurance that it will be successful in addressing such risks, and the failure
to do so could have a material adverse effect on its business.

         The officers and directors of the Company are currently involved in
other activities, and devote only a portion of their time to the specific
business affairs of the Company.

         We may have significant changes in the numbers of employees in the next
twelve months, contingent upon the continued growth and success of the Company's
Genotec Nutritionals operating subsidiary.

MERGERS AND ACQUISITIONS
------------------------

On September 21, 2006, the Company completed the previously announced
acquisition of Genotec Nutritionals, Inc, a New York based manufacturer and
distributor of nutritional supplements and vitamins. The Company issued
10,000,000 shares of its Class A Common Stock as part of the purchase price. The
Company also purchased $75,000 of Genotec's Series A Convertible Preferred
Stock, which represented working capital for the new subsidiary.

                                       23
<PAGE>

RESULTS OF OPERATIONS

SIX MONTHS ENDED DECEMBER 31, 2006 COMPARED TO SIX MONTHS ENDED DECEMBER 31,
----------------------------------------------------------------------------
2005
----

         Prior to the acquisition of Genotec Nutritionals, Inc ("Genotec") on
September 21, 2006, the Company had no sales and limited operations.
Consequently, comparison of the current period results to prior period results
may not be meaningful.

         Total sales for the six months ended December 31, 2006 and 2005 were
$426,276 and $0, respectively. The increase in sales in 2006 was derived from
the sales of nutritional supplements and vitamins by Genotec.

         Cost of sales for the six months ended December 31, 2006 and 2005 were
$154,254 and $0, respectively. The costs in 2006 represent the costs of bulk
supplies of raw ingredients, capsules and sealed powders, bottles, caps,
shipping containers, packaging and shipping of nutritional supplements and
vitamins by Genotec.

         Total operating expenses for the six months ended December 31, 2006 and
2005, were $590,132 and $371,992, respectively. The increase of $218,140 was
primarily due to the effect of the Genotec acquisition, increases in
professional and consulting fees related to the Genotec acquisition, and
increases in accounting fees for audit and review work associated with being a
public reporting company. Operating expenses increased by $153,750 for Genotec
administration, selling and marketing expenses. The most significant portion of
the Genotec expenses were related to payroll related expenses of $103,157, rent
and utilities of $17,042, insurance of $7,714 and selling expenses of $7,500.

         Total other (income) expense for the six months ended December 31, 2006
was an expense of $1,577,914. This total was comprised of amortization of the
discount on debt conversion of $290,439, loss on revaluation of derivatives of
$823,617, write-off of financing costs of $369,625, interest expense of $62,129
and liquidated damages of $81,424. These amounts are offset by interest income
of $9,128 and gain on disposition of derivative liability of $40,192. The other
expense for the six months ended December 31, 2005 was an expense of $790,755.
This total was comprised of amortization of the discount on debt conversion of
$500,000, liquidated damages of $150,000, interest expense of $115,278 and
write-off of financing costs of $40,192. These amounts are offset by interest
income of $14,715. Interest expense is related to accrued interest on the
Cornell Debentures and interest income is related to interest on the cash
accounts.

         Net loss from operations for the six months ending December 31, 2006
and 2005, was $1,896,024 and $1,162,747, respectively, as the result of the
factors discussed above. Comparison of the current period to the prior period
may not be meaningful for the reasons discussed above.

                                       24
<PAGE>

THREE MONTHS ENDED DECEMBER 31, 2006 COMPARED TO THREE MONTHS ENDED DECEMBER 31,
--------------------------------------------------------------------------------
2005
----

         Prior to the acquisition of Genotec Nutritionals, Inc ("Genotec") on
September 21, 2006, the Company had no sales and limited operations.
Consequently, comparison of the current period results to prior period results
may not be meaningful.

         Total sales for the three months ended December 31, 2006 and 2005 were
$400,135 and $0, respectively. The increase in sales in 2006 was derived from
the sales of nutritional supplements and vitamins by Genotec.

         Cost of sales for the three months ended December 31, 2006 and 2005
were $147,522 and $0, respectively. The costs in 2006 represent the costs of
bulk supplies of raw materials, capsules and sealed powders, bottles, caps,
shipping containers, packaging and shipping of nutritional supplements and
vitamins by Genotec.

         Total operating expenses for the three months ended December 31, 2006
and 2005, were $368,541 and $196,814, respectively. The increase of $171,727 was
primarily due to the effect of the Genotec acquisition, increases in
professional and consulting fees related to identifying and researching
potential acquisitions, and increases in accounting fees for audit and review
work associated with being a public reporting company. Operating expenses
increased by $141,507 for Genotec administration and selling and marketing
expenses. The most significant portion of the Genotec expenses were related to
payroll related expenses of $91,105, rent and utilities of $17,042, insurance of
$7,522 and selling expenses of $7,500.

         Total other (income) expense for the three months ended December 31,
2006 was an expense of $400,335. This total was comprised of amortization of the
discount on debt conversion of $145,220, loss on revaluation of derivatives of
$145,476, interest expense of $33,531 and liquidated damages of $79,818. These
amounts are offset by interest income of $3,710. The other expense for the three
months ended December 31, 2005 was an expense of $416,318. This total was
comprised of amortization of the discount on debt conversion of $250,000,
interest expense of $57,639, liquidated damages of $75,000 and write off of
financing costs of $40,192. These amounts are offset by interest income of
$6,513. Interest expense is related to accrued interest on the Cornell
Debentures and interest income is related to interest on the cash accounts.

         Net loss from operations for the three months ending December 31, 2006
and 2005, was $516,263 and $613,132, respectively, as the result of the factors
discussed above. Comparison of the current period to the prior period may not be
meaningful for the reason discussed above.

LIQUIDITY AND CAPITAL RESOURCES

         On April 1, 2005, we entered into a Securities Purchase Agreement with
Cornell for the sale of $2,500,000 of secured convertible debentures. The
agreement was amended and restated on July 20, 2006 and January 4, 2007 to
reflect the change in the funding formulas. Pursuant to the terms of the
agreement with Cornell, on April 1, 2005 we issued a secured convertible
debenture in the principal amount of $1,250,000. On July 20, 2006, the secured
convertible debenture was amended and restated and reissued in an aggregate
principal amount of

                                       25
<PAGE>

$1,330,308, which included accrued and unpaid interest on the original
convertible debenture of $80,308. On January 4, 2007, we issued a second secured
convertible debenture to Cornell in the principal amount of $625,000. In
addition, we will issue a third secured convertible debenture in the principal
amount of $625,000, two (2) business days prior to the date the registration
statement, registering the resale of the shares of Class A Common Stock issuable
upon conversion of convertible debentures and exercise of the warrants, is
declared effective by the SEC. These debentures will be convertible into Class A
common stock at the discretion of the holders. These transactions will require
the Company to register for resale a number of shares to facilitate these
financial transactions.

         The Company is seeking additional operating income opportunities
through potential acquisitions or investments. Such acquisitions or investments
may consume cash reserves or require additional cash or equity. Our working
capital and additional funding requirements will depend upon numerous factors,
including: (i) strategic acquisitions or investments; (ii) an increase to
current company personnel; (iii) the level of resources that we devote to sales
and marketing capabilities; (iv) technological advances; and (v) the activities
of competitors.

         To date, the Company has incurred substantial losses, and will require
financing for working capital to meet its operating obligations. While we have
raised sufficient working capital to fund our operations for what we believe
should be sufficient for the next 12 months, we will subsequently need to raise
additional capital to fund our future operations. We anticipate that we will
require financing on an ongoing basis for the foreseeable future to fund our
working capital needs.

         During the six months ended December 31, 2006 and 2005, the Company had
a net decrease in cash of $99,518 and $361,459, respectively. The Company's
principal use of funds during these periods was as follows:

         CASH FLOWS FROM OPERATING ACTIVITIES. The Company used $98,372 in cash
for operations in the six months ended December 31, 2006, a decrease of $262,531
compared to $360,903 in cash used for operations in the six months ending
December 31, 2005. The decrease in cash used in operations was primarily the
result of lower net cash loss (net loss after adding back non-cash items but
before considering changes in certain assets and liabilities) of $198,520 and a
favorable change in prepaid expenses of $157,938 offset by increases in accounts
receivable of $49,355 and decreases in accounts payable and accrued liabilities
of $68,948.

         CASH FLOWS FROM INVESTING ACTIVITIES. The Company used cash of $1,146
for investing activities in the six months ended December 31, 2006 for the
purchase of new office computer equipment for Genotec following the acquisition.
The Company used cash of $556 for investing activities in the six months ended
December 31, 2005 to upgrade the computers for the home office.

                                       26
<PAGE>

FORWARD LOOKING STATEMENTS - CAUTIONARY FACTORS

         Certain information included in this Form 10-QSB and other materials
filed or to be filed by us with the Securities and Exchange Commission (as well
as information included in oral or written statements made by us or on our
behalf), may contain forward-looking statements about our current and expected
performance trends, growth plans, business goals and other matters. These
statements may be contained in our filings with the Securities and Exchange
Commission, in our press releases, in other written communications, and in oral
statements made by or with the approval of one of our authorized officers.
Information set forth in this discussion and analysis contains various
"forward-looking statements" within the meaning of Section 27A of the Securities
Act of 1933 and Section 21E of the Securities Exchange Act of 1934. The Private
Securities Litigation Reform Act of 1995 (the "Act") provides certain "safe
harbor" provisions for forward-looking statements. The reader is cautioned that
such forward-looking statements are based on information available at the time
and/or management's good faith belief with respect to future events, and are
subject to risks and uncertainties that could cause actual performance or
results to differ materially from those expressed in the statements.
Forward-looking statements speak only as of the date the statement was made. We
assume no obligation to update forward-looking information to reflect actual
results, changes in assumptions or changes in other factors affecting
forward-looking information. Forward-looking statements are typically identified
by the use of terms such as "anticipate," "believe," "could," "estimate,"
"expect," "intend," "may," "might," "plan," "predict," "project," "should,"
"will," and similar words, although some forward-looking statements are
expressed differently. Although we believe that the expectations reflected in
such forward-looking statements are reasonable, we can give no assurance that
such expectations will prove to be correct.



                                       27
<PAGE>

ITEM 3. CONTROLS AND PROCEDURES

EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES.

The Company maintains a set of disclosure controls and procedures designed to
ensure that information required to be disclosed by us in our reports filed
under the Securities Exchange Act, is recorded, processed, summarized, and
reported within the time periods specified by the SEC's rules and forms.
Disclosure controls are also designed with the objective of ensuring that this
information is accumulated and communicated to our management, including our
chief executive officer and chief financial officer, as appropriate, to allow
timely decisions regarding required disclosure.

Our Board of Directors were advised by Bagell, Josephs, Levine and Company, LLC,
our independent registered public accounting firm, that during their performance
of review procedures for the period ended December 31, 2006, they have
identified a material weakness as defined in Public Company Accounting Oversight
Board Standard No. 2 in our internal control over financial reporting. Our
auditors have identified the following material weakness in our internal
controls:

     A material weakness in the Company's internal controls existed as of
     December 31, 2006. The material weakness was identified as the Company's
     limited segregation of duties amongst the Company's employees with respect
     to the Company's preparation and review of the Company's financial
     statements. This material weakness is the result of the Company's limited
     number of employees. This material weakness may affect management's ability
     to effectively review and analyze elements of the financial statement
     closing process and prepare consolidated financial statements in accordance
     with U.S. GAAP.

Subsequent to the notification from our independent registered public accounting
firm, our chief executive officer evaluated our internal controls and concurred
that, since the date of formation, our disclosure controls and procedures have
not been effective to ensure that information required to be included in our
periodic SEC filings is recorded, processed, summarized, and reported within the
time periods specified in the SEC rules and forms. However, at this time, our
resources and size prevent us from being able to employ sufficient resources to
enable us to have adequate segregation of duties within our internal control
system. The Company intends to remedy the material weakness by hiring additional
employees and reallocating duties, including responsibilities for financial
reporting, among the Company's employees as soon as the Company has the
financial resources to do so. Management is required to apply its judgment in
evaluating the cost-benefit relationship of possible changes in our disclosure
controls and procedures.

                                       28
<PAGE>

CHANGES IN INTERNAL CONTROLS

Management of the Company has evaluated, with the participation of the Chief
Executive Officer of the Company, any change in the Company's internal control
over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the
Exchange Act) that occurred during the fiscal quarter covered by this Quarterly
Report on Form 10-QSB. There was no change in the Company's internal control
over financial reporting identified in that evaluation that occurred during the
fiscal quarter covered by this Quarterly Report on Form 10-QSB that has
materially affected, or is reasonably likely to materially affect, the Company's
internal control over financial reporting, other than what has been reported
above.

RISK FACTOR RELATED TO CONTROLS AND PROCEDURES

The Company has limited segregation of duties amongst its employees with respect
to the Company's preparation and review of the Company's financial statements
due to the Company's limited number of employees, which is a material weakness
in internal controls , and if the Company fails to maintain an effective system
of internal controls, it may not be able to accurately report its financial
results or prevent fraud. As a result, current and potential stockholders could
lose confidence in the Company's financial reporting which could harm the
trading price of the Company's stock.

Effective internal controls are necessary for the Company to provide reliable
financial reports and prevent fraud. Inferior internal controls could cause
investors to lose confidence in the Company's reported financial information,
which could have a negative effect on the trading price of the Company's stock.
Management has found it necessary to limit the Company's administrative staffing
in order to conserve cash, until the Company's level of business activity
increases. As a result, there is very limited segregation of duties amongst the
administrative employees, and the Company and its independent public accounting
firm have identified this as a material weakness in the Company's internal
controls. The Company intends to remedy this material weakness by hiring
additional employees and reallocating duties, including responsibilities for
financial reporting, among the Company's employees as soon as there are
sufficient resources available. However, until such time, this material weakness
will continue to exist. Despite the limited number of administrative employees
and limited segregation of duties, management believes that the Company's
administrative employees are capable of following its disclosure controls and
procedures effectively.

                                       29
<PAGE>

                           PART II - OTHER INFORMATION


ITEM 6.        EXHIBITS


   31.1   Certification of Chief Executive and Chief Financial Officer pursuant
          to 18 U.S.C. Section 1350 as adopted pursuant to Section 302 of the
          Sarbanes-Oxley Act of 2002.

   32.1   Certification of Chief Executive and Chief Financial Officer pursuant
          to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the
          Sarbanes-Oxley Act of 2002.
























                                       30
<PAGE>

                                   SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused
this report to be signed on its behalf by the undersigned, thereunto duly
authorized.

MM2 Group, Inc.

By: /s/ Mark Meller                                   Date: February 20, 2007
   ----------------------
Mark Meller, President,
Chief Executive Officer and
Principal Accounting Officer






<PAGE>

                                INDEX OF EXHIBITS


   31.1   Certification of Chief Executive and Chief Financial Officer pursuant
          to 18 U.S.C. Section 1350 as adopted pursuant to Section 302 of the
          Sarbanes-Oxley Act of 2002.

   32.1   Certification of Chief Executive and Chief Financial Officer pursuant
          to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the
          Sarbanes-Oxley Act of 2002.





















                                       31